Search database
Filter
62
Text search: Drugs for neglected diseases initiative DNDi
Featured
Language
Document type
Studies & Reports
24
No document type
12
Strategic & Response Plan
6
Manuals
5
Resource Platforms
5
Guidelines
3
Videos
3
Fact sheets
2
Situation Updates
1
Infographics
1
Countries / Regions
Global
8
Latin America and the Carribbean
5
Ethiopia
3
Colombia
3
Africa
3
East and Southern Africa
2
West and Central Africa
2
Southern Africa
2
Uganda
1
India
1
Kenya
1
Brazil
1
Asia
1
Authors & Publishers
Drugs for Neglected Diseases initiative DNDi
15
World Health Organization WHO
10
et al.
6
DNDi - Drugs for neglected diseases initiative
5
Forsyth, C.
4
UNITAID
4
World Health Organisation (WHO)
3
World Health Organization (WHO)
3
Dahal, P.
2
Drugs for Neglected Diseases initiative DNDi - Latin America
2
A.Hill, T. Swan and K.Timmermans
1
Aksoy, S.
1
Avaria, A. et al.
1
Batista, C.
1
Bayão T.S., Cupertino M.C., Gomes A.P. et al
1
Bernal, O.
1
Bernal, OA
1
Bernhard, S.
1
Brindley, P. et al.
1
Brot für die Welt
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
Burri, C.
1
Caicedo Díaz, RA,
1
Chagas Coalition
1
Diseases
1
DNDi Latin America
1
Drugs for Neglected Diseases Initiative DNDi Latin America
1
Ethiopia, Ministry of Health
1
Fanjul, G.
1
Federal Ministry of Health, Ethiopia
1
GARDP Global Acntibiotic Research & Dedvelopment Partnership
1
Herazo, F.
1
Hotez, P.
1
Journal of the Brazilian Society of Tropical Medicine
1
Kaiser, M.
1
Khan, J.
1
Maguire, B.
1
Maguire, B.J.
1
Marchiol, A
1
Mäser, P.
1
McGloin, J.
1
Médecins Sans Frontières
1
Ministry of Health Ethiopia
1
Moriana, S.
1
MSF Access Campaign
1
Oritz, G.
1
Pan American Health Organization PAHO
1
Pan American Journal of Public Health
1
PLOS Neglected Tropical Diseases
1
Rashan, S.
1
Rashan, S. et al.
1
Sanmatino, M.
1
TB Alliance
1
Unicef
1
UNICEF, UNESCO, Asia Pacific Network of People living with HIV
1
Wamai, R.
1
World Health Organization (Western Pacific Region)
1
Zaidel, E.J.
1
Ziaggi, G.
1
Publication Years
Category
Countries
11
Clinical Guidelines
9
Pharmacy & Technologies
3
Public Health
1
Toolboxes
NTDs
41
HIV
3
Global Health Education
2
COVID-19
2
Pharmacy
2
TB
1
AMR
1
NCDs
1
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region. ... more
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are ... more
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discove ... more
La leishmaniasis es una enfermedad tropical desatendida sensible al clima, trasmitida por la picadura de insectos flebótomos y se calcula que amenaza a mil millones de personas en todo el mundo. Esta enfermedad altamente compleja se presenta de varias formas clínicas, causadas por 20 especies ... more
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-coun ... more
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin. The only treatment available ... more
Chagas is a parasitic disease that affects over 6 million people in the world. As the disease typically remains asymptomatic for years, new cases often go unnoticed and unreported, and most people with the disease are unaware of their condition. ... more
Website last accessed on 14.04.2023 Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments. For th ... more
La enfermedad de Chagas es parasitaria y afecta a más de 6 millones de personas en el mundo. Como normalmente es asintomática durante años, los nuevos casos suelen no detectarse ni reportarse y la mayoría de las personas con la enfermedad no tiene conciencia de su condición. Se diagnostica ... more
The Leishmaniasis East Africa Platform (LEAP) was established to support the generation of scientific evidence for the development and distribution of new treatments for leishmaniasis in Eastern Afr ... more
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where health systems face significant difficulties of diverse natures.
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P ... more
Cutaneous leishmaniasis is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often asso ... more
Diabetes Poster - Does your child show any of these symptoms?
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022 Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness ... more
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease. Endemic in 21 Latin American countries, the disease can be transmitted by vector insects called triatomines — also known as “kissing bugs” —, foods or beverages contaminated with th ... more
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.